HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ambroxol-theophylline-7-acetate

Also Known As:

acebrophylline

Networked: 6 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Lohar, Priyanka: 1 article (12/2019)
2.	Rathod, Rajeswari: 1 article (12/2019)
3.	Sahu, Amit Kumar: 1 article (12/2019)
4.	Sengupta, Pinaki: 1 article (12/2019)
5.	Sharma, Manish Kumar: 1 article (12/2019)
6.	Amberkar, Mohan Babu V: 1 article (03/2015)
7.	Kishore, Meenakumari Kamal: 1 article (03/2015)
8.	Kuriachan, Sanitha: 1 article (03/2015)
9.	Mohan, Manu K: 1 article (03/2015)
10.	Shahul, Hameed Aboobackar: 1 article (03/2015)

Related Diseases

1.	Asthma (Bronchial Asthma) 06/01/2007 - "On a clinical level, acebrophylline is therapeutically effective in patients with acute or chronic bronchitis, chronic obstructive or asthma-like bronchitis and recurrence of chronic bronchitis; it reduces the frequency of episodes of bronchial obstruction and reduces the need for beta2-agonists, and improves indexes of ventilatory function." 09/01/2014 - "To compare the efficacy of formoterol, montelukast and acebrophylline when used in combination with budesonide in patients with bronchial asthma and to determine their role in the improvement of the quality of life of patients. " 09/01/2014 - "Formoterol, montelukast or acebrophylline combined with inhaled corticosteroids have similar efficacy in the treatment of asthma." 12/01/2019 - "The combination of acebrophylline (ABP), levocetirizine (LCZ) and pranlukast (PRN) is used to treat allergic rhinitis, asthma, hay-fever and other conditions where patients experience difficulty in breathing. "
2.	Chronic Bronchitis 06/01/2007 - "On a clinical level, acebrophylline is therapeutically effective in patients with acute or chronic bronchitis, chronic obstructive or asthma-like bronchitis and recurrence of chronic bronchitis; it reduces the frequency of episodes of bronchial obstruction and reduces the need for beta2-agonists, and improves indexes of ventilatory function."
3.	Bronchitis 06/01/2007 - "On a clinical level, acebrophylline is therapeutically effective in patients with acute or chronic bronchitis, chronic obstructive or asthma-like bronchitis and recurrence of chronic bronchitis; it reduces the frequency of episodes of bronchial obstruction and reduces the need for beta2-agonists, and improves indexes of ventilatory function."
4.	Chronic Obstructive Pulmonary Disease (COPD) 05/01/1996 - "A total of 30 patients (27 males and 3 females) with a mean age of 62.6 +/- 3.9 years, suffering from chronic obstructive pulmonary disease were recruited into this open study to evaluate the clinical efficacy and the safety of a short course of treatment with 100 mg acebrophylline, twice daily for 14 days. " 05/01/1996 - "Effects of a short course of treatment with acebrophylline on the mucus rheological characteristics and respiratory function parameters in patients suffering from chronic obstructive pulmonary disease." 09/01/2014 - "This study reaffirms the rationale of use of Methylxanthines as add on therapy with LAMA in COPD management and cardiac safety level with Acebrophylline was considerable." 09/01/2014 - "The Effect of Acebrophylline vs Sustained Release Theophylline in Patients of COPD- A Comparative Study."
5.	Allergic Rhinitis 12/01/2019 - "The combination of acebrophylline (ABP), levocetirizine (LCZ) and pranlukast (PRN) is used to treat allergic rhinitis, asthma, hay-fever and other conditions where patients experience difficulty in breathing. "

Related Drugs and Biologics

1.	Budesonide (Pulmicort)
2.	Formoterol Fumarate (Oxis)
3.	montelukast (Singulair)
4.	Theophylline (Theon)
5.	Adrenal Cortex Hormones (Corticosteroids)
6.	levocetirizine
7.	pranlukast

Related Therapies and Procedures

1.	Therapeutics